MedPath

Tamsulosin effect on the treatment of urinary tract obstruction symptoms in wome

Phase 2
Recruiting
Conditions
rinary obstruction symptoms.
Registration Number
IRCT20230501058042N1
Lead Sponsor
Sabzevar University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
70
Inclusion Criteria

Female
Over 18 years old
With urinary tract obstruction symptoms

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
IPSS Score. Timepoint: At the beginning of the study and 4 weeks after taking the drug. Method of measurement: IPSS questionnaire.
Secondary Outcome Measures
NameTimeMethod
The result of uroflowmetry. Timepoint: The beginning of the study and 4 weeks after the start of taking the drug. Method of measurement: Objective uroflowmetry.
© Copyright 2025. All Rights Reserved by MedPath